{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:11:37Z","timestamp":1789103497938,"version":"build-2803163510"},"reference-count":59,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:p>The onset of menses for adolescents with physical or intellectual disabilities can affect their independence and add additional concerns for families at home, in schools, and in other settings. The pediatrician is the primary health care provider to explore and assist with the pubertal transition and menstrual management. Menstrual management of both normal and abnormal cycles may be requested to minimize hygiene issues, premenstrual symptoms, dysmenorrhea, heavy or irregular bleeding, contraception, and conditions exacerbated by the menstrual cycle. Several options are available for menstrual management, depending on the outcome that is desired, ranging from cycle regulation to complete amenorrhea. The use of medications or the request for surgeries to help with the menstrual cycles in teenagers with disabilities has medical, social, legal, and ethical implications. This clinical report is designed to help guide pediatricians in assisting adolescent females with intellectual and\/or physical disabilities and their families in making decisions related to successfully navigating menarche and subsequent menstrual cycles.<\/jats:p>","DOI":"10.1542\/peds.2016-0295","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T09:07:55Z","timestamp":1466413675000},"source":"Crossref","is-referenced-by-count":67,"title":["Menstrual Management for Adolescents With Disabilities"],"prefix":"10.1542","volume":"138","author":[{"given":"Elisabeth H.","family":"Quint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca F.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"COMMITTEE ON ADOLESCENCE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The North American Society for Pediatric and Adolescent Gynecology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula K.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Alderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora C.","family":"Breuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arik V.","family":"Marcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca F.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"issue":"7","key":"2021120904592453400_B1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/adc.2009.174680","article-title":"The impact of menstruation in adolescents with disabilities related to cerebral palsy.","volume":"95","author":"Zacharin","year":"2010","journal-title":"Arch Dis Child"},{"issue":"3","key":"2021120904592453400_B2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jadohealth.2013.04.014","article-title":"Trends in menstrual concerns and suppression in adolescents with developmental disabilities.","volume":"53","author":"Kirkham","year":"2013","journal-title":"J Adolesc Health"},{"issue":"1","key":"2021120904592453400_B3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.2006-1115","article-title":"Sexuality of children and adolescents with developmental disabilities.","volume":"118","author":"Murphy","year":"2006","journal-title":"Pediatrics"},{"key":"2021120904592453400_B4","unstructured":"US Census Bureau. School-Aged Children with Disabilities in U.S. Metropolitan Areas: 2010. Available at: https:\/\/www.census.gov\/prod\/2011pubs\/acsbr10-12.pdf. Accessed May 4, 2015"},{"issue":"2","key":"2021120904592453400_B5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pop.2007.04.010","article-title":"Intellectual disability (mental retardation) in children and adolescents.","volume":"34","author":"Pratt","year":"2007","journal-title":"Prim Care"},{"issue":"6","key":"2021120904592453400_B6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1017\/S0012162299000857","article-title":"Premature sexual development in individuals with neurodevelopmental disabilities.","volume":"41","author":"Siddiqi","year":"1999","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"2021120904592453400_B7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1017\/S0012162206222229","article-title":"Age of menarche in girls with autism spectrum conditions.","volume":"48","author":"Knickmeyer","year":"2006","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"2021120904592453400_B8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/00006250-200611000-00059","article-title":"ACOG Committee Opinion No. 349, November 2006: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign.","volume":"108","author":"American College of Obstetricians and Gynecologists","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2021120904592453400_B9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0306-4530(02)00128-2","article-title":"Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.","volume":"28","author":"Kinon","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"2021120904592453400_B10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1196\/annals.1429.030","article-title":"Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents.","volume":"1135","author":"Joffe","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"2021120904592453400_B11","first-page":"135","article-title":"Amenorrhea in the adolescent","volume-title":"Emans, Laufer, Goldstein\u2019s Pediatric and Adolescent Gynecology","author":"Emans","year":"2012","edition":"6th ed."},{"issue":"6","key":"2021120904592453400_B12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/AOG.0b013e3181c6f922","article-title":"Menstrual manipulation for adolescents with disabilities. ACOG Committee Opinion No. 448.","volume":"114","author":"American College of Obstetricians and Gynecologists","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2021120904592453400_B13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpag.2009.04.005","article-title":"Gynecologic issues of adolescents with Down syndrome, autism, and cerebral palsy.","volume":"23","author":"Burke","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2021120904592453400_B14","volume-title":"Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents","author":"Hagan","year":"2008","edition":"3rd ed."},{"issue":"1","key":"2021120904592453400_B15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1054-139X(01)00400-1","article-title":"Sexual behaviors of physically disabled adolescents in the United States.","volume":"31","author":"Cheng","year":"2002","journal-title":"J Adolesc Health"},{"key":"2021120904592453400_B16","first-page":"131","article-title":"Adolescent health care","volume-title":"Medicolegal Issues in Pediatrics","author":"McDonnell","year":"2012"},{"key":"2021120904592453400_B17","doi-asserted-by":"publisher","author":"Braverman","year":"2010","DOI":"10.1542\/peds.2010-1564"},{"issue":"2 pt 1","key":"2021120904592453400_B18","first-page":"421","article-title":"ACOG Committee Opinion No. 534: well-woman visit.","volume":"120","author":"American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2021120904592453400_B19","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-2299","article-title":"Contraception for adolescents.","volume":"134","author":"Committee on Adolescence","year":"2014","journal-title":"Pediatrics"},{"issue":"5","key":"2021120904592453400_B20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/GCO.0b013e32832e493e","article-title":"Extended cycling or continuous use of hormonal contraceptives for female adolescents.","volume":"21","author":"Gold","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"2","key":"2021120904592453400_B21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/aogs.12036","article-title":"Continuous use of oral contraceptives: an overview of effects and side-effects.","volume":"92","author":"Hee","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"2021120904592453400_B22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1542-2011.2012.00250.x","article-title":"Extended and continuous combined contraceptive regimens for menstrual suppression.","volume":"57","author":"Jacobson","year":"2012","journal-title":"J Midwifery Womens Health"},{"issue":"2","key":"2021120904592453400_B23","first-page":"4","article-title":"First chewable oral contraceptive.","volume":"38","year":"2004","journal-title":"FDA Consum"},{"issue":"7","key":"2021120904592453400_B24","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception.","volume":"7","author":"Edelman","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2021120904592453400_B25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial.","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021120904592453400_B26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial.","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2021120904592453400_B27","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"issue":"24","key":"2021120904592453400_B28","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception.","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2021120904592453400_B29","doi-asserted-by":"crossref","first-page":"R221","DOI":"10.1530\/EJE-14-0527","article-title":"Epidemiology of hormonal contraceptives-related venous thromboembolism.","volume":"171","author":"Hugon-Rodin","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2021120904592453400_B30","unstructured":"United States Medical Eligibility Criteria (US MEC) for Contraceptive Use. 2010. Available at: www.cdc.gov\/reproductivehealth\/unintendedpregnancy\/usmec.htm. Accessed May 4, 2015"},{"issue":"5","key":"2021120904592453400_B31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0010-7824(90)90077-9","article-title":"Clinical experience with the progestogen-only pill.","volume":"42","author":"Broome","year":"1990","journal-title":"Contraception"},{"issue":"4","key":"2021120904592453400_B32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10508-007-9302-0","article-title":"The influence of hormonal contraception on mood and sexual interest among adolescents.","volume":"37","author":"Ott","year":"2008","journal-title":"Arch Sex Behav"},{"issue":"3","key":"2021120904592453400_B33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","article-title":"Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.","volume":"74","author":"Arias","year":"2006","journal-title":"Contraception"},{"issue":"7","key":"2021120904592453400_B34","first-page":"CD008815","article-title":"Progestin-only contraceptives: effects on weight.","volume":"7","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120904592453400_B35","unstructured":"World Health Organization. Technical Consultation on the Effects of Hormonal Contraception on Bone Health: Summary Report. Geneva, Switzerland: World Health Organization: 2005. Available at: http:\/\/whqlibdoc.who.int\/hq\/2007\/WHO_RHR_07.08_eng.pdf. Accessed May 4, 2015"},{"issue":"6","key":"2021120904592453400_B36","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.AOG.0000450758.95422.c8","article-title":"Committee Opinion No. 602: depot medroxyprogesterone acetate and bone effects.","volume":"123","author":"American College of Obstetricians and Gynecologists","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2021120904592453400_B37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jadohealth.2006.03.011","article-title":"Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine.","volume":"39","author":"Cromer","year":"2006","journal-title":"J Adolesc Health"},{"key":"2021120904592453400_B38","first-page":"CD009849","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies.","volume":"8","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2021120904592453400_B39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2010-2961","article-title":"Clinical report\u2014bone densitometry in children and adolescents.","volume":"127","author":"Bachrach","year":"2011","journal-title":"Pediatrics"},{"issue":"6","key":"2021120904592453400_B40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1440-1754.2009.01506.x","article-title":"Assessing the skeleton in children and adolescents with disabilities: avoiding pitfalls, maximising outcomes. A guide for the general paediatrician.","volume":"45","author":"Zacharin","year":"2009","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"2021120904592453400_B41","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-2173","article-title":"Optimizing bone health in children and adolescents.","volume":"134","author":"Golden","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"2021120904592453400_B42","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/AOG.0b013e3182723b7d","article-title":"ACOG Committee Opinion No. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.","volume":"120","author":"Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2021120904592453400_B43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09513590.2011.588751","article-title":"Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: cross-sectional study in a Central European district.","volume":"28","author":"Stoegerer-Hecher","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2021120904592453400_B44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpag.2012.05.005","article-title":"Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay.","volume":"25","author":"Hillard","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"2021120904592453400_B45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-0528.2009.02372.x","article-title":"The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities.","volume":"117","author":"Pillai","year":"2010","journal-title":"BJOG"},{"issue":"3","key":"2021120904592453400_B46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpag.2012.01.005","article-title":"Retrospective review of intrauterine device in adolescent and young women.","volume":"25","author":"Alton","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"2021120904592453400_B47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpag.2013.08.010","article-title":"Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities.","volume":"27","author":"Savasi","year":"2014","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2021120904592453400_B48","unstructured":"SKYLA. (levonorgestrel-releasing intrauterine system) [package insert]. Available at: http:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Skyla_PI.pdf. Accessed May 4, 2015"},{"issue":"2","key":"2021120904592453400_B49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons.","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"issue":"17","key":"2021120904592453400_B50","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/WNL.0b013e3181bd8295","article-title":"Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives.","volume":"73","author":"Wegner","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"2021120904592453400_B51","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1542-2011.2012.00180.x","article-title":"Contraception and antiepileptic drugs.","volume":"57","author":"Guillemette","year":"2012","journal-title":"J Midwifery Womens Health"},{"key":"2021120904592453400_B52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/IJWH.S28872","article-title":"Diagnosis and management of catamenial seizures: a review.","volume":"4","author":"Verrotti","year":"2012","journal-title":"Int J Womens Health"},{"issue":"13","key":"2021120904592453400_B53","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2165\/11317010-000000000-00000","article-title":"Interactions between herbal medicines and prescribed drugs: an updated systematic review.","volume":"69","author":"Izzo","year":"2009","journal-title":"Drugs"},{"issue":"6","key":"2021120904592453400_B54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2004.11.004","article-title":"Interaction of St. John\u2019s Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding.","volume":"71","author":"Murphy","year":"2005","journal-title":"Contraception"},{"issue":"6","key":"2021120904592453400_B55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1365-2125.2003.02005.x","article-title":"Gerbers, Haszhke M, Bitzer J, Drewe J. Interaction of St. John\u2019s wort with low dose oral contraceptive therapy: a randomized controlled trial.","volume":"56","author":"Pfrunder","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"2021120904592453400_B56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2125.2012.04395.x","article-title":"Herbal hepatotoxicity: a critical review.","volume":"75","author":"Teschke","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2021120904592453400_B57","first-page":"CD000400","article-title":"Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.","volume":"1","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120904592453400_B58","first-page":"413","article-title":"Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety.","volume":"4","author":"Leminen","year":"2012","journal-title":"Int J Womens Health"},{"issue":"1","key":"2021120904592453400_B59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.AOG.0000263915.70071.29","article-title":"ACOG Committee Opinion No. 371: sterilization of women, including those with mental disabilities.","volume":"110","author":"American College of Obstetricians and Gynecologists","year":"2007","journal-title":"Obstet Gynecol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-0295\/921635\/peds_20160295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-0295\/921635\/peds_20160295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T22:03:57Z","timestamp":1639087437000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/138\/1\/e20160295\/52591\/Menstrual-Management-for-Adolescents-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,1]]},"published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2016-0295","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,1]]},"article-number":"e20160295"}}